Show simple item record

dc.contributor.authorCole, M P
dc.contributor.authorTodd, Ian D
dc.contributor.authorWilkinson, Peter M
dc.date.accessioned2011-12-30T12:19:02Z
dc.date.available2011-12-30T12:19:02Z
dc.date.issued1973-05
dc.identifier.citationCyclophosphamide and nandrolone decanoate in the treatment of advanced carcinoma of the breast--results of a comparative controlled trial of the agents used singly and in combination. 1973, 27 (5):396-9 Br. J. Canceren
dc.identifier.issn0007-0920
dc.identifier.pmid4576562
dc.identifier.urihttp://hdl.handle.net/10541/199533
dc.description.abstractA random trial in which cyclophosphamide, nandrolone decanoate and the two drugs in combination were used in the treatment of advanced breast carcinoma is described. The results suggest that it is preferable to use cyclophosphamide on its own.
dc.language.isoenen
dc.subject.meshAdministration, Oral
dc.subject.meshAdult
dc.subject.meshBreast Neoplasms
dc.subject.meshClinical Trials as Topic
dc.subject.meshCyclophosphamide
dc.subject.meshDrug Combinations
dc.subject.meshFemale
dc.subject.meshHair
dc.subject.meshHair Removal
dc.subject.meshHumans
dc.subject.meshInjections, Intravenous
dc.subject.meshLeukocytes
dc.subject.meshMiddle Aged
dc.subject.meshNandrolone
dc.subject.meshVomiting
dc.titleCyclophosphamide and nandrolone decanoate in the treatment of advanced carcinoma of the breast--results of a comparative controlled trial of the agents used singly and in combination.en
dc.typeArticleen
dc.contributor.departmentChristie Hospital and Holt Radium Institute, Manchesteren
dc.identifier.journalBritish Journal of Canceren
dc.identifier.pmcidPMC2008797
html.description.abstractA random trial in which cyclophosphamide, nandrolone decanoate and the two drugs in combination were used in the treatment of advanced breast carcinoma is described. The results suggest that it is preferable to use cyclophosphamide on its own.


This item appears in the following Collection(s)

Show simple item record